BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36837601)

  • 1. A Comparison of Two Hormonal Fertility Monitoring Systems for Ovulation Detection: A Pilot Study.
    Mu Q; Fehring RJ
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837601
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete Cycle Mapping Using a Quantitative At-Home Hormone Monitoring System in Prediction of Fertile Days, Confirmation of Ovulation, and Screening for Ovulation Issues Preventing Conception.
    Wegrzynowicz AK; Beckley A; Eyvazzadeh A; Levy G; Park J; Klein J
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557055
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring.
    Bouchard TP; Fehring RJ; Mu Q
    Expert Rev Mol Diagn; 2021 Dec; 21(12):1349-1360. PubMed ID: 34714210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing is crucial: Some critical thoughts on using LH tests to determine women's current fertility.
    Lobmaier JS; Bachofner LM
    Horm Behav; 2018 Nov; 106():A2-A3. PubMed ID: 30092174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Quantitative Hormone Monitoring to Identify the Postpartum Return of Fertility.
    Bouchard TP; Schweinsberg K; Smith A; Schneider M
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004057
    [No Abstract]   [Full Text] [Related]  

  • 6. Accuracy of the Ovulon fertility monitor to predict and detect ovulation.
    Fehring RJ; Schlaff WD
    J Nurse Midwifery; 1998; 43(2):117-20. PubMed ID: 9581098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of the peak day of cervical mucus as a biological marker of fertility.
    Fehring RJ
    Contraception; 2002 Oct; 66(4):231-5. PubMed ID: 12413617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecundability in relation to use of mobile computing apps to track the menstrual cycle.
    Stanford JB; Willis SK; Hatch EE; Rothman KJ; Wise LA
    Hum Reprod; 2020 Oct; 35(10):2245-2252. PubMed ID: 32910202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements.
    Behre HM; Kuhlage J; Gassner C; Sonntag B; Schem C; Schneider HP; Nieschlag E
    Hum Reprod; 2000 Dec; 15(12):2478-82. PubMed ID: 11098014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the BIOSELF 110 fertility indicator.
    Ismail M; Arshat H; Pulcrano J; Royston P; Spieler J
    Contraception; 1989 Jan; 39(1):53-71. PubMed ID: 2642781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CUE Fertility Monitor compared to ultrasound and LH peak measurements for fertile time ovulation detection.
    Freundl G; Bremme M; Frank-Herrmann P; Baur S; Godehardt E; Sottong U
    Adv Contracept; 1996 Jun; 12(2):111-21. PubMed ID: 8863906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the fertile phase as determined by the Clearplan Easy Fertility Monitor and self-assessment of cervical mucus.
    Fehring RJ; Raviele K; Schneider M
    Contraception; 2004 Jan; 69(1):9-14. PubMed ID: 14720613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of salivary estrogen levels for detecting the fertile period.
    Günther V; Bauer I; Hedderich J; Mettler L; Schubert M; Mackelenbergh MT; Maass N; Alkatout I
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():38-42. PubMed ID: 26319654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature.
    Regidor PA; Kaczmarczyk M; Schiweck E; Goeckenjan-Festag M; Alexander H
    Gynecol Endocrinol; 2018 Mar; 34(3):256-260. PubMed ID: 29082805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Lady Free Biotester in determining the fertile period.
    Fehring RJ; Gaska N
    Contraception; 1998 May; 57(5):325-8. PubMed ID: 9673839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study.
    Howards PP; Schisterman EF; Wactawski-Wende J; Reschke JE; Frazer AA; Hovey KM
    Am J Epidemiol; 2009 Jan; 169(1):105-12. PubMed ID: 18974081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and prediction of the fertile window using NaturalCycles.
    Berglund Scherwitzl E; Lindén Hirschberg A; Scherwitzl R
    Eur J Contracept Reprod Health Care; 2015; 20(5):403-8. PubMed ID: 25592280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of urinary reproductive hormone measurements using a novel smartphone connected reader.
    Pattnaik S; Das D; Venkatesan VA
    Sci Rep; 2023 Jun; 13(1):9227. PubMed ID: 37286704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Likelihood of Pregnancy Using an App-Connected Ovulation Test System: A Randomized Controlled Trial.
    Johnson S; Stanford JB; Warren G; Bond S; Bench-Capon S; Zinaman MJ
    J Womens Health (Larchmt); 2020 Jan; 29(1):84-90. PubMed ID: 31483187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.